• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Etoricoxib Taro
    / Taro


    Active Ingredient
    Etoricoxib 30, 60, 90, 120 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    28 X 30 mg

    not in the basket chart

    Film Coated Tablets

    14 X 60 mg

    not in the basket chart

    Film Coated Tablets

    14 X 90 mg

    not in the basket chart 45477

    Film Coated Tablets

    7 X 120 mg

    not in the basket chart

    Related information


    Dosage

    Osteoarthritis: The recommended dosage is 30 mg once a day, can be increased to a maximum of 60 mg once a day, if necessary.
    Rheumatoid arthritis: The recommended dosage is 60 mg once a day, can be increased to a maximum of 90 mg once a day, if necessary.
    Ankylosing spondylitis: The recommended dosage is 60 mg once a day, can be increased to a maximum of 90 mg once a day, if necessary.
    Acute pain conditions: Etoricoxib should be used only for the acute painful period.
    Gout: The recommended dosage is 120 mg once a day, which should only be used for the acute painful period, limited to a maximum of 8 days of treatment.
    Postoperative dental surgery pain: The recommended dosage is 90 mg once daily, limited to a maximum of 3 treatment days.


    Indications

    Etoricoxib 30 mg: Indicated for the symptomatic relief of osteoarthritis (OA).
    Etoricoxib 60 mg: Indicated for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis.
    Etoricoxib 90 mg: Indicated for the symptomatic relief of rheumatoid arthritis (RA) and ankylosing spondylitis. For the short-term treatment of moderate pain associated with dental surgery.
    Etoricoxib 120 mg: Indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.


    Contra-Indications

    Hypersensitivity to active substance or any of its excipients.
    Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and COX-2 inhibitors.
    Patients with peptic ulcer, bleeding or intestinal bleeding.
    Patients with severe hepatic disease.
    Patients with a severe renal disease.
    Pregnancy. Lactation.
    Patients under 16 years of age.
    Patients with IBD: Crohn’s disease, ulcerative colitis, colitis.
    Patients with uncontrolled hypertension.
    Patients with heart failure (moderate or severe).
    Patients with ischemic heart disease or peripheral vascular disease (e.g. DVT).
    Patients with any kind of stroke, transient ischemic attack (TIA).
    Patients with history of myocardial infarction.


    Special Precautions

    Please refer to the license holder for further details.


    Manufacturer
    Synthon Hispania S.L., Barcelona, Spain
    CLOSE